Perfil de la empresa · Healthcare

Bio-Rad Laboratories Inc

BIO · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
1 de enero de 1966
Empleados
7450
Precio actual
$282.44
En vivo · 22 de junio de 2026
Compra razonable
≤ $190
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
45/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $282.44 En vivo · Dentro del rango de valor intrínseco razonable

Rango de valoración compuesto · conservador $170–$190 / razonable $276–$374 / optimista $466–$510. A $282.44, Dentro del rango de valor intrínseco razonable.

Al publicar $297.09 (2 de julio de 2026)

18 de mayo de 2026 Update Needs review

Elliott reportedly builds sizable stake in Bio-Rad

WSJ reported Elliott built a sizable Bio-Rad stake and plans to push for improved share performance.

Possible impact:May affect expectations for governance changes, asset value realization and possible strategic actions.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

Capitalización8049,62 MUS$
Ingresos (TTM)2589,9 MUS$
EBITDA444,8 MUS$
Margen neto6,52 %
ROE2,5 %
PER (TTM)49,97
PER previsto34,01
PEG1,19
BPA6,02 US$
Rango de 52 semanas236,73 US$ – 343,12 US$
Precio objetivo de analistas297,00 US$
Recomendación de analistas4.0 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.